These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18782686)

  • 1. Lymphoid myeloid lineage specification.
    Graf T
    Semin Immunol; 2008 Aug; 20(4):205-6. PubMed ID: 18782686
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system.
    Laslo P; Pongubala JM; Lancki DW; Singh H
    Semin Immunol; 2008 Aug; 20(4):228-35. PubMed ID: 18771937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells: the road not taken.
    Hock H; Orkin SH
    Nature; 2005 Jun; 435(7042):573-5. PubMed ID: 15931202
    [No Abstract]   [Full Text] [Related]  

  • 4. A s-myly route toward lymphoid differentiation.
    Kee BL; Dias S
    Immunity; 2009 Apr; 30(4):474-6. PubMed ID: 19371711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are dendritic cells afraid of commitment?
    O'Garra A; Trinchieri G
    Nat Immunol; 2004 Dec; 5(12):1206-8. PubMed ID: 15549120
    [No Abstract]   [Full Text] [Related]  

  • 6. Myeloid lineage of human endothelial outgrowth cells circulating in blood and vasculogenic endothelial-like cells in the diseased vessel wall.
    Liu C; Wang S; Metharom P; Caplice NM
    J Vasc Res; 2009; 46(6):581-91. PubMed ID: 19571578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine myelomonocytic markers and cell populations.
    Ezquerra A; Revilla C; Alvarez B; Pérez C; Alonso F; Domínguez J
    Dev Comp Immunol; 2009 Mar; 33(3):284-98. PubMed ID: 18586052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissues and interpretation of proliferative and inflammatory lesions of mice and rats.
    Rehg JE; Bush D; Ward JM
    Toxicol Pathol; 2012; 40(2):345-74. PubMed ID: 22434870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid lineage fate decision of hematopoietic stem cells.
    Akashi K
    Ann N Y Acad Sci; 2009 Sep; 1176():18-25. PubMed ID: 19796229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.
    Sarrazin S; Mossadegh-Keller N; Fukao T; Aziz A; Mourcin F; Vanhille L; Kelly Modis L; Kastner P; Chan S; Duprez E; Otto C; Sieweke MH
    Cell; 2009 Jul; 138(2):300-13. PubMed ID: 19632180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in myeloid differentiation.
    Fatica A; Rosa A; Ballarino M; De Marchis ML; Rasmussen KD; Bozzoni I
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1201-5. PubMed ID: 19021525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoietic cell apoptosis.
    Strasser A
    Curr Opin Immunol; 2007 Oct; 19(5):485-7. PubMed ID: 17719758
    [No Abstract]   [Full Text] [Related]  

  • 13. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
    Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
    J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in the renewal, differentiation and homeostasis of immune cells.
    Clarke AJ; Simon AK
    Nat Rev Immunol; 2019 Mar; 19(3):170-183. PubMed ID: 30531943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy.
    Kawamoto H; Katsura Y
    Trends Immunol; 2009 May; 30(5):193-200. PubMed ID: 19356980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage specification and heterogeneity of T follicular helper cells.
    Yu D; Batten M; Mackay CR; King C
    Curr Opin Immunol; 2009 Dec; 21(6):619-25. PubMed ID: 19896816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
    J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From phagocyte diversity and activation to probiotics: back to Metchnikoff.
    Mantovani A
    Eur J Immunol; 2008 Dec; 38(12):3269-73. PubMed ID: 19039773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.
    Bousquet M; Quelen C; Rosati R; Mansat-De Mas V; La Starza R; Bastard C; Lippert E; Talmant P; Lafage-Pochitaloff M; Leroux D; Gervais C; Viguié F; Lai JL; Terre C; Beverlo B; Sambani C; Hagemeijer A; Marynen P; Delsol G; Dastugue N; Mecucci C; Brousset P
    J Exp Med; 2008 Oct; 205(11):2499-506. PubMed ID: 18936236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.